Pharmacological treatments of childhood and adolescent depression;Les traitements pharmacologiques de la dépression chez l'enfant et l'adolescent

Journal de Pharmacie Clinique

Volumn 20, Issue 3, 2001, Pages 171-177

  L'Eilde Balcon C ^a   Lemonnier, E ^a   Chamoux, F ^a   Borgnis Desbordes, N ^a  

^a Serv Hosp Univ Psychiat Adultes   (France)

Author keywords

Adolescent; Antidepressive agents; Child; Depression; Serotonin uptake inhibitors; Tricyclics

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; FLUOXETINE; FLUVOXAMINE MALEATE; IMIPRAMINE; IPRONIAZID; MAPROTILINE; MIANSERIN; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; MOTIVAL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TOLOXATONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNCLASSIFIED DRUG; VENLAFAXINE; VILOXAZINE;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CHILD; CHILD PSYCHIATRY; CHILDHOOD DISEASE; CLINICAL TRIAL; DEPRESSION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; EUROPE; HUMAN; PREVALENCE; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY;

EID: 0035149982     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Multicenter open-label sertraline study in adolescent outpatients with major depression
2. Fluvoxamine open-label treatment of adolescent inpatient with obsessive compulsive disorder or depression
3. School phobia: A therapeutic trial with clomipramine and short-term outcome
4. Prise en charge institutionnelle et médicamenteuse
5. Childhood and adolescent depression: A review of the past 10 years. Part II
6. Should we use antidepressant medications for children and adolescents with depressive disorders?
7. Response to desipromine treatment in adolescent major depression
8. An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression
9. Lo dépression vue par le pédopsychiatre
10. Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults
11. Pharmacokinetics in children and adolescents
12. Dépression de I'enfant: Une entité long-temps méconnue
13. Treatment of childhood and adolescent depression with mianserin
14. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
15. Putative determinants of paroxetine response in pediatric patients with major depression
16. Poroxetine pharmacokinetics in depressed children and odolescents
17. Child and adolescent bipolar disorder: A review of the past ten years
18. Double-blind placebo-controlled study of nortriptyline in depressed children using a fixed plasma level design
19. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a fixed plasma level design
20. Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds
21. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency
22. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
23. The effect of concomitant disorders in childhood depression on predicting treatment response
24. Fluoxetine in children and adolescents with mood disorders: A chart review of efficacy and adverse effects
25. Clinique de la dépression de l'adolescent
26. Amitriptyline in children with major depressive disorder: A double-blind crossover pilot study
27. Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial
28. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment
29. Dépression et phénomènes hallucinatoires et/ou délirants chez l'enfant et l'adolescent
30. Depressive disorders in childhood I- A longitudinal prospective study of characteristics and recovery
31. Depressive disorders in childhood III- A longitudinal study of comorbidity with and risk for conduct disorders
32. Clinical effects of amitriptyline in adolescent depression
33. Response to desipramine treatment in adolescent depression: A fixed-dose placebo-controlled trial
34. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depresssion
35. Venlafoxine in the treatment of children and adolescents with major depression
36. Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial
37. An open study of the effects of sertraline on adolescent major depression
38. Imipramine treatment of depressed children: A double-blind pilot study
39. Depression in prepubertal children: Dexamethasone nonsuppression predicts differential response to imipramin versus placebo
40. Imipramine in prepubertal major depressive disorders
41. A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents
42. Paroxetine in children with major depressive disorder: On open trial
43. Mood stabilizers in children and adolescents
44. Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up
45. Case study: Two additional sudden deaths with tricyclic antidepressants
46. Pharmacokinetics of lithium carbonate in children
47. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents